Artivion
Manufacturing · Georgia, United States · 1,500 Employees
View Company Info for Free
About
Headquarters
1655 Roberts Blvd NW, Kennesaw, Georgia, 30144,...Phone Number
(770) 419-3355Website
www.artivion.comRevenue
$368.2 MillionStock Symbol
AORTIndustry
Most Recent Scoops
Who is Artivion
Artivion Org Chart
Is Artivion your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Artivion launches new products
Funding: Get notified immidiatlly once Artivion has new funding data
Click to see if Artivion had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Artivion
Website visits: Recent activity has been detected on your website
Artivion, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Artivion has recently received funding, and reach out quickly before it becomes old news!
Check out if Artivion is spiking on competitors!
Earning: See what the market has to say on Artivion recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Artivion
Compare insights from companies similar to Artivion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Artivion Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Artivion Tech Stack
A closer look at the technologies used by Artivion
Most Recent Scoops
Artivion News & Media
Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis
ATLANTA, Dec. 9, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that the U.S. Food and Drug Administration (FDA) has granted a Humanitarian Device Exemption (HDE) for use of the AMDS Hybrid...Artivion Reports Third Quarter 2024 Financial Results
Third Quarter Highlights: Achieved revenue of $95.8 million in the third quarter of 2024 versus $87.9 million in the third quarter of 2023, an increase of 9% on a GAAP basis and 10% on a non-GAAP constant currency basis Net loss was ($2.3) million or ($0.05) per fully diluted share and...Artivion to Participate in Upcoming Investor Conferences
ATLANTA, Nov. 5, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences. Artivion's management team will present at the upcoming Stifel 2024...Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results
ATLANTA, Oct. 24, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2024 financial results will be released on Thursday, November 7, 2024 after the market closes. On that day, the...
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Artivion
Artivion is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair.... Read More